Navigation Links
Diabetes treatment may also provide protection against endometrial cancer
Date:4/5/2011

Research led by Warwick Medical School at the University of Warwick has found that Metformin, a drug treatment used to treat diabetes and also in women with Polycystic vary syndrome (PCOS), may potentially provide protection against endometrial cancer.

Endometrial cancer is the most common malignancy of the female genital tract and the fourth most common cancer in women in the UK and the US. Up to a third of PCOS women also have endometrial hyperplasia which, in turn predisposes these women to endometrial cancer. PCOS affects 5%-10% of women of reproductive age, where Metformin ameliorates insulin resistance and hyperinsulinemia in these women, but also long-term use of Metformin improves ovulation and menstrual cycle regularity.

Recent research has found that Metformin has anti-cancer properties e.g. in breast cancer. Given that insulin resistant states, e.g. obesity, diabetes and PCOS are more at risk of developing endometrial cancer, the Warwick researchers studied the effects of metformin treatment on endometrial cancer cells. The researchers used serum from control and PCOS (before and after metformin treatment) subjects and carried out basic scientific experiments on endometrial cancer cells. The experiments revealed a decrease in endometrial cancer cell invasiveness in sera from metformin treated PCOS women.

The researchers found that serum samples from PCOS women who had completed the 6 month course of Metformin the rate of spread of endometrial cancer cells was around 25% lower than in the serum samples from PCOS women who had not started that treatment.

The principal investigators, Dr Harpal Randeva and Dr Bee K Tan, at Warwick Medical School said: "We are very excited about our findings, which reveal the significant impact of Metformin therapy use on human endometrial cancer cells. However, it is prudent that further research to explore if Metformin would actually be beneficial clinically as adjuvant therapy in endometrial cancer; this would need to be addressed through a randomized controlled trial."


'/>"/>

Contact: Dr. Harpal S. Randeva
Harpal.Randeva@warwick.ac.uk
44-247-657-2552
University of Warwick
Source:Eurekalert  

Related medicine news :

1. Add Cancer to Health Risks of Diabetes: Study
2. Avoiding or controlling diabetes may reduce cancer risk and mortality
3. Bariatric surgery reduces long-term cardiovascular risk in diabetes patients
4. Bariatric surgery highly cost-effective treatment for type 2 diabetes in the obese
5. International Diabetes Federation supports surgery to treat diabetes
6. Nick Jonas Lives Large, Despite Diabetes
7. Actos Cut Risk of Prediabetes Becoming Diabetes in Study
8. Study Ties Asthma to Higher Odds for Diabetes, Heart Disease
9. Metabolite levels may be able to improve diabetes risk prediction
10. Analysis Confirms Diabetes Drug May Harm the Heart
11. Diabetes Surgery 2nd World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes treatment may also provide protection against endometrial cancer
(Date:7/20/2017)... Richmond, Va. (PRWEB) , ... July 20, 2017 , ... ... Daniel McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief ... of Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced ... Proceeds will be used to complete regulatory submissions and fund final engineering and ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today ... existing adherence automation lines. The ATP® Mini and InspectRx® Mini are ... standard products, but at a size and price point that can help pharmacies ...
(Date:7/20/2017)... ... 20, 2017 , ... A budget proposal to switch to an alternate consumer ... adjustment (COLA) is a bad deal for older and disabled Americans, says The ... grow even more slowly than the conventional one that is currently used to determine ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
(Date:7/5/2017)... 2017 Wolfmet 3D  printed tungsten collimator manufactured by M&I ... manufacturing combine to progress molecular radiotherapy imaging. In ... unable to accurately quantify the radiation absorbed by those patients ... success of this radiotherapy treatment has been available — that ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
Breaking Medicine Technology: